11.12.2013 14:20 Uhr, Quelle: Wallstreet online

Enzo Biochem and Flagship Biosciences Partner to Provide Tissue-Based Companion Diagnostics Offering Complete Solution for In Situ Hybridization Development to Pharmaceutical Companies

Enzo Biochem Inc. (NYSE:ENZ) and Flagship Biosciences LLC, of Boulder, CO, today announced a partnership in tissue-based companion diagnostics that will enable personalized diagnosis and treatment of disease. The firms are …

Weiterlesen bei Wallstreet online